Up a level |
Kapp, FG and Kretschmer, S and Beckmann, CCA and Wäsch, L and Molitor, A and Carapito, R and Schubert, M and Lucas, N and Conrad, S and Poignant, S and Isidor, B and Rohlfs, M and Kisaarslan, AP and Schanze, D and Zenker, M and Schmitt-Graeff, A and Strahm, B and Peters, A and Yoshimi, A and Driever, W and Zillinger, T and Günther, C and Maharana, S and Guan, K and Klein, C and Ehl, S and Niemeyer, CM and Unal, E and Bahram, S and Hauck, F and Lee-Kirsch, MA and Speckmann, C (2023) C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib. In: Clinical Immunology, 256 .
Devarapu, Satish Kumar and Kumar VR, Santhosh and Rupanagudi, Khader Valli and Kulkarni, Onkar P and Eulberg, Dirk and Klussmann, Sven and Anders, Hans-Joachim (2017) Reprint of “Dual blockade of the pro-inflammatory chemokine CCL2 and the homeostatic chemokine CXCL12 is as effective as high dose cyclophosphamide in murine proliferative lupus nephritis”. In: Clinical Immunology, 185 . pp. 119-127. ISSN 15216616